Abbott Laboratories
SIX:ABT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
SIX:ABT
|
US |
|
C
|
Clearside Biomedical Inc
XMUN:CLM
|
US |
Wall St Price Targets
ABT Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABT is 108.5456 CHF with a low forecast of 84.0252 CHF and a high forecast of 129.1305 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABT's stock price target?
Price Target
108.5456
CHF
According to Wall Street analysts, the average 1-year price target for ABT is 108.5456 CHF with a low forecast of 84.0252 CHF and a high forecast of 129.1305 CHF.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 9%.
What is the Gross Profit forecast for Abbott Laboratories?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 5 years is 10%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 5 years is 16%.
What is the Pre-Tax Income forecast for Abbott Laboratories?
Projected CAGR
19%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 5 years is 17%.
